6DUP | pdb_00006dup

CRYSTAL STRUCTURE OF PXR IN COMPLEX WITH COMPOUND 7


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.30 Å
  • R-Value Free: 
    0.266 (Depositor) 
  • R-Value Work: 
    0.226 (Depositor), 0.225 (DCC) 

wwPDB Validation 3D Report Full Report

Validation slider image for 6DUP

Ligand Structure Quality Assessment 


This is version 1.3 of the entry. See complete history

Literature

Amelioration of PXR-mediated CYP3A4 induction by mGluR2 modulators.

Vaz, R.J.Li, Y.Chellaraj, V.Reiling, S.Kuntzweiler, T.Yang, D.Shen, H.Batchelor, J.D.Zhang, Y.Chen, X.McLean, L.R.Kosley Jr., R.

(2018) Bioorg Med Chem Lett 28: 3194-3196

  • DOI: https://doi.org/10.1016/j.bmcl.2018.08.022
  • Primary Citation Related Structures: 
    6DUP

  • PubMed Abstract: 

    This work describes the rational amelioration of Cytochrome P450 4/5 (CYP3A4/5) induction through the Pregnane-X Receptor (PXR) pathway in a series of compounds that modulate the metabotropic glutamate Receptor 2 (mGluR2) via an allosteric mechanism. The compounds were initially shown to induce CYP3A4/5 via the gold-standard induction assay measured in primary human hepatocytes. This was followed up by testing the compounds in a PXR assay which correlated well with the assay in primary cells. Further, one of the compounds was crystallized with PXR (pdb code 6DUP). Analysis of this co-crystal structure, together with previously published PXR co-crystal structures, lead to modification ideas. The compounds synthesized based on these ideas were shown not to be CYP3A4/5 inducers. The mGluR2 activity of the resulting compounds was maintained.


  • Organizational Affiliation
    • Integrated Drug Discovery, Sanofi US, 153-2nd Ave., Waltham, MA 02451, USA. Electronic address: roy.vaz@sanofi.com.

Macromolecule Content 

  • Total Structure Weight: 78.76 kDa 
  • Atom Count: 4,720 
  • Modeled Residue Count: 562 
  • Deposited Residue Count: 688 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Nuclear receptor subfamily 1 group I member 2
A, B
344Homo sapiensMutation(s): 0 
Gene Names: NR1I2PXR
UniProt & NIH Common Fund Data Resources
Find proteins for O75469 (Homo sapiens)
Explore O75469 
Go to UniProtKB:  O75469
PHAROS:  O75469
GTEx:  ENSG00000144852 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupO75469
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
HCJ

Query on HCJ



Download:Ideal Coordinates CCD File
C [auth A](2S)-2-({[3'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]oxy}methyl)-2,3-dihydro-7H-[1,3]oxazolo[3,2-a]pyrimidin-7-one
C20 H15 F3 N2 O3
AYYWUDDPGRDIQB-KRWDZBQOSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.30 Å
  • R-Value Free:  0.266 (Depositor) 
  • R-Value Work:  0.226 (Depositor), 0.225 (DCC) 
Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 84.034α = 90
b = 88.926β = 90
c = 106.452γ = 90
Software Package:
Software NamePurpose
CNXrefinement
HKL-2000data collection
SCALEPACKdata scaling
PHASERphasing
HKL-2000data reduction

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2018-08-29
    Type: Initial release
  • Version 1.1: 2018-09-12
    Changes: Data collection, Database references
  • Version 1.2: 2018-10-17
    Changes: Data collection, Database references
  • Version 1.3: 2024-03-13
    Changes: Data collection, Database references